[ORGANIZATION]

Imfinzi

Featured in 2 tracked stories · first seen 3 months ago

Situations

[ACTIVE] [HEALTH] [GR] [US]

ES-SCLC combination therapy clinical trial results

2 clusters · 20 sources · last updated about 12 hours ago

Latest: New lung cancer therapy reduces death risk by 58%

Results from the Phase 3 DeLLphi-305 clinical trial indicate that a combination of Amgen’s Imdelltra (tarlatamab) and AstraZeneca’s Imfinzi (durvalumab) significantly improves survival outcomes for patients with extensiv